CD19 and coronary artery disorder: In CAD patients, CD19 was the only immune marker for which a significant progressive trend was observed with regard to serum vitamin D concentration ranges, with a greater proportion of C19-positive cells identified in patients with lower serum 25(OH)D2 levels (Table 4).